The Efficacy and Safety of Imeglimine in Elderly People with Type 2 Diabetes Mellitus
Not Applicable
Recruiting
- Conditions
- Elderly people with type 2 diabetes (65 years and older)
- Registration Number
- JPRN-UMIN000050556
- Lead Sponsor
- Kitasato University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients on multiple insulin injection therapy (basal and bolus insulin therapy) 2) Patients with renal dysfunction (glomerular filtration rate (eGFR) <45 mL/min/1.73 m2) 3) Patients with severe anemia (Hb < 10g/dL) 4) Patients who are using an implantable medical device (e.g. pacemaker) 5) Patients with severe cognitive impairment 6) Patients with active malignant tumors 7) Patients who are judged by the principal investigator or subinvestigator to be inappropriate to participate in this clinical research
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glycemic profilse after treatment with Imeglimin
- Secondary Outcome Measures
Name Time Method